Amneal Pharmaceuticals, Inc.

AMRXNASDAQHealthcare● Active

$13.75

+$0.23(+1.70%)

Market Cap$4.4B

P/E Ratio—

52W High$15.42

52W Low$7.07

Avg Volume1.8M

Open$13.58

Beta1.32

Overview

Amneal Pharmaceuticals, Inc. (AMRX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

AMRX · net income · updated Jun 8, 2026

Core profitability metrics

AMRX · net income · margin · TTM · CAGR

Net income was $72.1M for FY2025 (fiscal year ending 2025-12-31), up 161.6% year-over-year. Net profit margin was 2.4%. Based on available data, Amneal Pharmaceuticals, Inc. has been profitable since at least 2014.

FY2025 Net Income$72.1M▲ +161.6% YoY

Trailing 12M (TTM)$122.4Mtrailing 4 quarters sum

Net Profit Margin2.4%$72.1M ÷ $3.02B

YoY Change+161.6%—

5-Year CAGR-4.6%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2014

▸ FMP /income-statement · Annual · AMRX net income history · AMRX profit margin

Annual net income data

AMRX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$72.1M▲ +161.6%2.4%$3.02B

FY2024Loss−$116.9M▼ 39.2%-4.2%$2.79B

FY2023Loss−$84.0M▲ +35.4%-3.5%$2.39B

FY2022Loss−$130.0M▼ 1323.5%-5.9%$2.21B

FY2021$10.6M▼ 88.3%0.5%$2.09B

Net income vs peers (Healthcare)

AMRX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Amneal Pharmaceuticals, Inc.YOU

AMRX

$72.1M+161.6%2.4%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Amneal Pharmaceuticals, Inc. (AMRX) reported net income of $72.1M for FY2025 (fiscal year ending 2025-12-31), up 161.6% year-over-year. The net profit margin was 2.4% — meaning the company kept $0.02 of every dollar of revenue as profit.

Based on available data, Amneal Pharmaceuticals, Inc. has been profitable since at least 2014. Net income reached a peak of $207.4M in FY2016. Data available for 12 fiscal years.

Amneal Pharmaceuticals, Inc.'s net profit margin was 2.4% for FY2025, based on the latest annual results.

Investors sometimes search for "Amneal Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from AMRX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

AMRX net income · 5 questions

Amneal Pharmaceuticals, Inc. is profitable. The company reported net income of $72.1M for FY2025, a net profit margin of 2.4%. Net income was up 161.6% year-over-year. Based on available data, Amneal Pharmaceuticals, Inc. has been profitable since at least 2014.

is AMRX profitabledoes AMRX make a profitAMRX profitabilityAMRX profitable company

▸ Source: FMP /income-statement · GAAP · Amneal Pharmaceuticals, Inc. · Amneal Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026